Trials / Completed
CompletedNCT00111878
Study to Evaluate MEDI-534 in Healthy Adults
Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (planned)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to describe the safety and tolerability of a single dose of MEDI-534 when administered to healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MEDI-534 |
Timeline
- Start date
- 2005-04-01
- Completion
- 2005-12-01
- First posted
- 2005-05-27
- Last updated
- 2007-07-03
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00111878. Inclusion in this directory is not an endorsement.